Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients

Neurofibromatosis type 1 (NF1) is one of the commonest autosomal dominant disorders in man, affecting 1 in 3500 people. Consensus clinical criteria were defined in 19871 and revised and updated in 1997.2 Cafe au lait spots, axillary freckling, dermal neurofibromas, and Lisch nodules of the iris are the most common manifestations of this disorder. Most of the clinical symptoms of the disease are age dependent and considerable phenotypic variability has been described both between and within families.3,4 This genetic disorder is caused by mutations in the NF1 gene, one of the largest human genes, composed of 60 exons and spanning more than 300 kb of genomic DNA.5 The determination of the NF1 mutational spectrum has been complex owing to the large number of coding exons and the considerable mutational heterogeneity. Until recently, most diagnostic laboratories just offered linkage analysis for NF1 patients, which excluded diagnosis of the 50% of de novo cases. The use of techniques based on the analysis of NF1 mRNA greatly facilitated the number of mutations identified and NF1 screening efficiency, depicting a mutational NF1 spectrum.6–8 These studies highlighted the importance of splicing defects in molecular NF1 pathology and, despite most patients bearing unique mutations, they suggested the recurrence of several mutations. Here we present our experience with the direct analysis of the whole NF1 coding region in 474 unrelated subjects suspected of having NF1. Mutations have been identified in 189 patients, 85 of them bearing recurrent mutations. ### Patients and families Four hundred and seventy-four unrelated subjects suspected of having NF1 were analysed for mutations in the NF1 gene. Included in these 474 cases are 80 NF1 patients studied previously.6 Clinical data confirming NF1 diagnostic criteria were available in 201 (42%) of the subjects studied and in the remaining cases either no …

[1]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[2]  P. O'Connell,et al.  A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations , 1990, Cell.

[3]  D. Easton,et al.  An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes. , 1993, American journal of human genetics.

[4]  M. Wigler,et al.  A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity , 1993, Molecular and cellular biology.

[5]  X. Estivill,et al.  Novel alleles, hemizygosity and deletions at an Alu-repeat within the neurofibromatosis type 1 (NF1) gene. , 1993, Human molecular genetics.

[6]  S. Colman,et al.  Two NF1 mutations: Frameshift in the GAP‐related domain, and loss of two codons toward the 3′ end of the gene , 1994, Human mutation.

[7]  P. O'Connell,et al.  Genomic organization of the neurofibromatosis 1 gene (NF1). , 1995, Genomics.

[8]  P. Nürnberg,et al.  On unequal allelic expression of the neurofibromin gene in neurofibromatosis type 1. , 1995, Human molecular genetics.

[9]  S. Purandare,et al.  Characterisation of a novel splice donor mutation affecting position +1 in intron 18 of the NF-1 gene. , 1995, Human molecular genetics.

[10]  S. Antonarakis,et al.  Two novel mutations affecting mRNA splicing of the neurofibromatosis type 1 (NF1) gene , 1996, Human Mutation.

[11]  B. Korf,et al.  The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. , 1997, Journal of the American Medical Association (JAMA).

[12]  P. Nürnberg,et al.  Nearby stop codons in exons of the neurofibromatosis type 1 gene are disparate splice effectors. , 1998, American journal of human genetics.

[13]  V. Park,et al.  Neurofibromatosis type 1 (NF1): a protein truncation assay yielding identification of mutations in 73% of patients. , 1998, Journal of medical genetics.

[14]  M. Upadhyaya,et al.  Evaluation of the protein truncation test and mutation detection in the NF1 gene: mutational analysis of 15 known and 40 unknown mutations , 1999, Human Genetics.

[15]  M. Schuelke,et al.  Mutation screening of neurofibromatosis type 1 (NF1) exons 28 and 29 with single strand conformation polymorphism (SSCP): Five novel mutations, one recurrent transition and two polymorphisms in a panel of 118 unrelated NF1 patients , 1999, Human mutation.

[16]  K. Wimmer,et al.  Illegitimate splicing of the NF1 gene in healthy individuals mimics mutation-induced splicing alterations in NF1 patients , 2000, Human Genetics.

[17]  P. Nürnberg,et al.  Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. , 2000, American journal of human genetics.

[18]  D. Vidaud,et al.  NF1 gene analysis focused on CpG‐rich exons in a cohort of 93 patients with neurofibromatosis type 1 , 2000, Human mutation.

[19]  G Mortier,et al.  Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects , 2000, Human mutation.

[20]  P. Nürnberg,et al.  Analysis of the NF1 gene by temperature gradient gel electrophoresis reveals a high incidence of mutations in exon 4b , 2000, Electrophoresis.

[21]  X. Estivill,et al.  Cold shock induces the insertion of a cryptic exon in the neurofibromatosis type 1 (NF1) mRNA. , 2000, Nucleic acids research.

[22]  X. Estivill,et al.  Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. , 2000, Human molecular genetics.

[23]  V. Riccardi,et al.  Associations of clinical features in neurofibromatosis 1 (NF1) , 2000, Genetic epidemiology.

[24]  Jo Vandesompele,et al.  Quantification of splice variants using real-time PCR , 2001, Nucleic Acids Res..

[25]  D. Cooper,et al.  Evaluation of denaturing high performance liquid chromatography (DHPLC) for the mutational analysis of the neurofibromatosis type 1 (NF1) gene , 2001, Human Genetics.

[26]  J. Vandesompele,et al.  Quantification of NF1 transcripts reveals novel highly expressed splice variants , 2002, FEBS letters.

[27]  S. Thomson,et al.  RT-PCR splicing analysis of the NF1 open reading frame , 2002, Human Genetics.

[28]  B. Korf,et al.  NF1 mutations in neurofibromatosis 1 patients with plexiform neurofibromas , 2002, Human mutation.

[29]  X. Estivill,et al.  Two further cases of mutation R1947X in the NF1 gene: screening for a relatively common recurrent mutation , 1995, Human Genetics.

[30]  P. Robinson,et al.  Two recurrent nonsense mutations and a 4 bp deletion in a quasi-symmetric element in exon 37 of the NF1 gene , 1995, Human Genetics.

[31]  X. Estivill,et al.  Recurrence of a nonsense mutation in the NF1 gene causing classical neurofibromatosis type 1 , 1991, Human Genetics.